Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
	Apr. 20, 2023	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Schedule of Equity Method Investments [Line Items]
Cash purchase price					$ 235,000
Conversion of Stock, Shares Issued				8,340,000
Series A Convertible Preferred Stock [Member]
Schedule of Equity Method Investments [Line Items]
Conversion of Stock, Shares Issued		13,579,710	13,579,710	13,579,710	13,579,710
Series B Convertible Preferred Stock [Member]
Schedule of Equity Method Investments [Line Items]
Conversion of Stock, Shares Issued		13,579,710	13,579,710	13,579,710	13,579,710
Convertible Debt Securities [Member]
Schedule of Equity Method Investments [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		104,490,131	83,125,488	104,490,131	83,125,488
Share-Based Payment Arrangement, Option [Member]
Schedule of Equity Method Investments [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		8,120,000	6,020,000	8,120,000	6,020,000
Warrant [Member]
Schedule of Equity Method Investments [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		15,387,050	15,387,050	15,387,050	15,387,050
Discontinued Operations, Held-for-Sale [Member] | Purchase Agreement [Member]
Schedule of Equity Method Investments [Line Items]
Cash purchase price	$ 2,300,000